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PHARMACOLOGIC 
INTERVENTION FOR 
ISCHEMIC BRAIN EDEMA 
AFTER RETROGRADE 
CEREBRAL PERFUSION 
Retrograde cerebral perfusion has recently been the focus of interest as a simple new 
technique of brain protection during aortic arch operations. We undertook the experi- 
mental protocol of 120 minutes of retrograde cerebral perfusion followed by antegrade 
reperfusion. Eighteen mongrel dogs were used. Retrograde cerebral perfusion was 
maintained at a flow rate of 150 to 250 ml/min to keep the perfusion pressure from 15 
to 25 mm Hg. Animals were divided into three groups as follows: in group I, no 
treatment was received uring and after retrograde cerebral perfusion; in group II, 
mannitol (2 gm/kg) was administered before cardiopulmonary b pass was restarted; 
and in group III, antivasospastic substance (1,2-bis[nicotinamido]-propane) was con- 
tinuously injected uring and after retrograde cerebral perfusion (1 mg/kg per minute). 
Cerebral blood flow decreased during retrograde cerebral perfusion in all three groups. 
Cerebrovascular resistance showed marked increases 30 and 60 minutes after cardio- 
pulmonary bypass was restarted in group I compared with the values in groups I1 and 
III (group h 3.35 -+ 0.73 and 5.00 -+ 1.57 mm Hg/ml per 100 gm per minute; group II: 
1.30 +- 0.33 and 1.03 - 0.17 mm Hg/ml per 100 gm per minute; group III: 1.24 + 0.41 
and 0.98  - 0.24 mm Hg/ml per 100 gm per minute). The oxygen extraction level was 
reduced by cooling, but it rose to a higher level as a result of significant desaturation of
returned blood even in deep hypothermia during retrograde cerebral perfusion. Both 
cerebral metabolic rate of oxygen and cerebral metabolic rate of glucose remained at low 
levels during retrograde cerebral perfusion. Ratios of cerebral blood flow to cerebral 
metabolic rate of oxygen and cerebral blood flow to cerebral metabolic rate of glucose 
were markedly reduced during retrograde cerebral perfusion. Intracranial pressure 
showed significant increases 30 and 60 minutes after cardiopulmonary b pass was 
restarted in group I compared with values in group II or group HI (group I: 22.7 :- 2.8 
and 20.6 - 5.1 mm Hg; group II: 6.3 -+ 1.8 and 5.3 - 1.3 mm Hg; group III: 4.2 :~- 1.7 
and 7.7 + 2.8 mm Hg). Water content of the brain tissue in group I (77.54% _ 0.29%) 
was significantly higher than that in group II (74.71% --- 0.76%) or group HI (74.14% - 
0.48%). These data suggest that the supply of oxygen or glucose by retrograde cerebral 
perfusion is not enough to maintain sutficient cerebral metabolism, which may cause 
brain edema during antegrade r perfusion. Therefore cerebral protection via pharma- 
cologic agents is recommended to prevent neurologic omplications during aortic arch 
operations with the use of retrograde cerebral perfusion. (J TItORAC CARDIOVASC SURG 
1995;109:1173-81) 
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of the brain while cerebral blood flow is interrupted 
is considered to be the most important priority 
during aortic arch operations. 1 As supportive tech- 
niques, deep hypothermic irculatory arrest, a' 3 se.- 
lective cerebral perfusion, 4' 5 and retrograde cere- 
bral perfusion (RCP) 6' v have been used during the 
period of arch vessel occlusion. 
Among these techniques, RCP has recently been 
the focus of interest as a simple new technique of 
brain protection during aortic arch operation, a-I° 
This method may be useful because it does not 
require cannulation and crossclamping of arch ves- 
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Fig. 1. Experimental circuit. FA, Femoral artery; LV, left 
ventricle; RA, right atrium; Heat Ex, heat exchanger. 
sels, and it may enhance cerebral protection during 
circulatory arrest. However, it is not clear whether 
this method provides adequate cerebral oxygenation 
or how long it can be done safely, .1 and therefore 
further studies are necessary to clarify these prob- 
lems. We undertook the experimental protocol of 
120 minutes of RCP followed by 60 minutes of 
antegrade reperfusion with two objectives: (1) to 
define the pattern of cerebral response to RCP and 
(2) to evaluate whether pharmacologic ntervention 
enhances neuronal recovery after RCP. In this 
study, the protocol and techniques were designed to 
duplicate those used in a routine clinical setting. 
Material  and methods 
All animals received humane care in compliance with 
the "Principles of Laboratory Animal Care" formulated 
by the National Society for Medical Research and the 
"Guide for the Care and Use of Laboratory Animals" 
prepared by the Institute of Laboratory Animal Resources 
and published by the National Institutes of Health (NIH 
Publication No. 86-23, revised 1985). 
Animal preparation. Eighteen mongrel dogs weighing 
10 to 15 kg were used in this study. Anesthesia was 
induced with ketamine hydrochloride (10 mg/kg) intra- 
muscularly and thiamylal sodium (5 mg/kg) intravenously. 
Tracheostomy was done, and the animals were maintained 
on positive-pressure v ntilation with 1% entturane and 
99% oxygen and paralyzed with pancuronium bromide. 
The lungs were not inflated during cardiopulmonary 
bypass (CPB) or RCP. Anesthesia was maintained with 
pentobarbital sodium (1 mg/kg per hour) through a
catheter placed in the right carotid artery until RCP was 
started. A nasopharyngeal temperature probe was set in 
place, and bilateral internal maxillary vein catheters were 
inserted for blood perfusion and monitoring of perfusion 
pressure during RCP. A subdural catheter was inserted 
through a burr hole in the skull for intracranial pressure 
monitoring. 
Extraeorporeal circulation technique. A median ster- 
notomy was done, and each animal received heparin 
sodium (300 U/kg) intravenously. The left femoral artery 
and right atrium were cannulated, and CPB was estab- 
lished at a flow rate of 70 ml/kg per minute during cooling 
and rewarming. A cannula was passed from the left atrium 
into the left ventricle to permit decompression f the left 
side of the heart during extracorporeal circulation. RCP 
was established with blood perfusion through the bilateral 
internal maxillary veins and drainage through the right 
atrium cannula and left ventricle venting cannula (Fig. 1). 
RCP was maintained at a flow rate of 150 to 250 ml/min to 
keep the perfusion pressure from 15 to 25 mm Hg. The 
extracorporeal circulation circuit consisted of a nonpulsa- 
tile roller pump and a Shiley S-070/S oxygenator (Shiley 
Inc., Irvine, Calif.) primed with lactated Ringer's olution, 
1000 U heparin sodium, 3.5 gm sodium bicarbonate, and 
300 ml blood from another dog. A CDI-300 continuous 
in-line blood gas analyzer (3M Healthcare, Irvine, Calif.) 
was used to control circuit blood gas levels. 12 No pharma- 
cologic agents were given to control blood pressure during 
this study. 
Cerebral blood flow and cerebrovascular esistance. 
Cerebral blood flow (CBF) was measured simultaneously 
by the hydrogen clearance method with a UH meter 
(Unique Medical Co., Tokyo, Japan) and laser Doppler 
flQwmetry with the Peri Flux PF3 machine (Perimed Co., 
Stockholm, Sweden). A hydrogen electrode and a'laser 
Doppler probe were inserted into the cerebral cortex of 
the parietal lobe through the burr holes in the skull. 
Cerebrovascular resistance (CVR) was calculated as 
follows: CVR (millimeters of Mercury per milliliter per 
100 gm) = (mean arterial pressure - mean internal 
maxillary venous pressure)/CBF (during CPB), or CVR = 
(mean internal maxillary venous pressure - mean arterial 
pressure)/CBF (during RCP). 
Cerebral metabolism. During the experimental proto- 
col, perfused and returned blood were sampled to mea- 
sure cerebral metabolism. Perfused blood was obtained 
from the extracorporeal circulation circuit. Returned 
blood was obtained from the internal maxillary venous 
catheter during CPB or from the carotid arterial catheter 
during RCP. Cerebral metabolic rate of oxygen (CMRO2) 
and cerebral metabolic rate of glucose (CMRGlu) were 
calculated as follows: CMRO2 (milliliters per 100 gm per 
minute) = CBF × (perfused 0 2 content - returned 02 
content)/100, and CMRGlu (milligrams per 100 gm per 
minute) = CBF × (perfused glucose level - returned 
glucose level)/100. 
Perfused and returned blood 02 content was measured 
with an ABL3 instrument (Radiometer, Copenhagen, 
Denmark), and glucose levels were measured with a 
TOECHO III instrument (Kodama Co., Tokyo, Japan). 
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Table I. Mean arterial pressure, internal maxillary venous pressure, nasopharyngeal temperature, and 
parameters of the perfused blood during the protocol 
CPB RCP reCPB 
Variable 10 rnin 60 rnin 30 rain 60 rain 90 rain 120 min 10 min 30 min 60 min 
MAP (mm Hg) 
Group I 70 --_ 12 
Group II 51 + 7 
Group III 89 z 18 
IMVP (ram Hg) 
Group I 11 ± 2 
Group II 12 + 1 
Group III 7 ± 1 
NP temp. (° C) 
Group I
Group II 
Grgu p III 
Hb (gm/dl) 
Group I
Group II 
Group III 
O2 cont. (vol %) 
Group I
Group II 
Group III 
Glucose (mg/dl) 
Group I 203 + 14 
Group II 190 -- 23 
Group III 189 _+ 19 
60±8 3±1 3±1 3±1 3±1 73±12 78210 67±8 
4928 4±2 422 422 4±2 46±4 54±7 50±6 
47±7 2±1 2±1 2±1 1±1 59±10 57±5 57±6 
8~2 24±3 22±3 22±3 22~3 10±1 11±1 12±1 
11±1 22±1 21±1 22±1 22±1 11±3 13±1 13±3 
7±2 16=2 17±3 16±2 15±2 12±1 13±1 13±1 
34.9±0.6 21.3__0.7 20.1+_0.5 20.0-1.1 19.7_+1.2 19.8_+1.0 21.2_+0.9 29.3_+2.3 35.9+_0.5 
34.6-0.6 20.1--0.4 20.0_+0.9 19.6-+1.1 19.3_+1.3 19.2_+1.4 19.3+_1.7 28.5+_1.7 34.9 0.7 
33.4_+0.8 19.4_+0.4 17.5_+0.7 17 1-+1.0 16.5_+1.0 16.2+1.0 17.8+0.9 28.1+1.4 35.3_+0.7 
14.6 - 0.9 15.2 _+ 0.9 15.0 +_ 0.9 14.3 -- 0.7 14.8 _+ 0.5 13.5 -+ 0.7 14.2 _+ 0.4 14.4 _+ 0.4 15.7 - 0.6 
14.4 - 0.9 13.8 -- 0.8 13.6 _+ 0.6 12.9 -- 0.6 13.2 -+ 0.6 12.7 -+ 0.8 12.2 _+ 0.9 12.1 -+ 0.7 12.2 -+ 0.7 
13.8+1.5 13.5+1.3 13.1+1.4 12.9±1.6 13.2+1.5 13.0±1.5 12.8+1.8 13.4+1.5 13.5_+1.4 
21.7-+1.3 23.2_+1.3 23.2_+1.3 22.2+0.9 22.9_+0.7 21.6+0.5 21.7+_0.7 21.8+0.6 23.5_+0.9 
21.3_+1.4 20.6_+1.0 21.1_+0.8 20.0_+0.7 20.6+_0.8 19.9_+1.2 19.1_+1.3 18.9_+1.  18.7_+1.0 
20.9+_1.8 20.6_+2.0 20.3+_2.2 19.5_+2.7 20.4_+2.2 20.1_+2.2 19.8_+2.6 20.0_+2.2 20.1._+2.0 
215 + 19 226 + 13 243 + 15" 215 + 17 220 + 12 239 -+ 22 274 + 34 237 + 45 
202 _+ 32 190 + 14 186 --+ 9* 184 -+ 11 181 + 15 189 + 14 233 -+ 23 247 +_ 37 
172 _+ 9 215 +_ 9 202 _+ 6 223 -+ 25 212 _+ 30 192 _+ 19 269 +- 30 294 +-- 36 
reCBP, Restarting of CPB; MAP, Mean arterial pressure; IMVP, internal maxillary venous pressure; NP temp., nasopharyngeal temperature; Hb, hemoglobin; 
02 cont., oxygen content. 
*p < 0.05. 
Experimental protocol. CPB was initiated at a flow rate 
of 70 ml/kg per minute, and cooling was done to a 20 ° C 
nasopharyngeal temperature with an average cooling time 
of 38.3 + 1.7 minutes. After a brief period of circulatory 
arrest, RCP was started and continued for 120 minutes. 
Then CPB was reestablished, and rewarming was done 
over 60 minutes to 36 ° C. When the temperature ached 
36 ° C, animals were weaned from CPB. 
Animals were randomly assigned to one of three exper- 
imental groups: in group I (n = 6, control group), no 
treatment was received uring and after RCP; in group II 
(n = 6), mannitol (2 gm/kg) was administered by bolus 
injection into the oxygenator reservoir before CPB was 
restarted; and in group III (n = 6), antivasospastic 
substance (1,2-bis[nicotinamido]-propane) 13 was injected 
continuously into the internal maxillary veins during RCP 
and into the right carotid artery during rewarming by CPB 
(1 mg/kg per minute). 
Data were collected at nine points during the experi- 
mental protocol as follows: 10 and 60 minutes after the 
initiation of CPB (before and after cooling); 30, 60, 90, 
and 120 minutes after the initiation of RCP; and 10, 30, 
and 60 minutes after the restarting of CPB (before, 
during, and after rewarming). 
When CPB was terminated, the animal was immedi- 
ately killed and the brain was removed to evaluate the 
degree of brain edema. Water content was calculated 
from the comparison of dry and wet weights. 
Statistical analysis. All results are expressed as mean 
plus or minus the standard error of the mean. Values were 
compared at the various times by analysis of variance with 
repeated measures, and differences at each time were 
tested by factorial analysis of variance. When the F ratio 
of the analysis of variance was significant, he differences 
were tested by Scheffe's test. Statistical significance was 
tested at the 95% confidence level. 
Results 
Table I shows mean arterial  pressure, mean inter- 
nal maxil lary venous pressure, nasopharyngeal  tem- 
perature and hemoglobin level, oxygen content, or 
glucose level of  the perfused blood measured for 
each animal during the xper imental  protocol.  Dur-  
ing the RCP period,  internal maxil lary venous pres- 
sure exceeded the arterial  pressure. The pressure 
gradient between the internal maxil lary veins and 
systemic artery caused retrograde CBF, which was 
evidenced by "dark"  b lood with a low oxygen level 
being returned to the carot id artery. Nasopharyn-  
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Fig. 3. Changes of CVR during experimental protocol, reCPB, Restarting of CPB. 
geal temperature gradually decreased uring the 
RCP period, which is thought to be one of the 
protective ffects of RCP. A statistically significant 
difference in glucose level 60 minutes after initiation 
of RCP was observed between group I and group II, 
but this difference was probably of no physiologic 
importance. There were no statistically significant 
differences among the three groups in the other 
variables examined. 
CBF and CVR. The changes of CBF and CVR 
are shown in Figs. 2 and 3, respectively. In all three 
groups, CBF decreased at 20°C nasopharyngeal 
temperature before RCP and decreased still more 
during RCP. CVR showed a marked increase after 
CPB was restarted in group I, and it was significantly 
higher than the values in groups II and III at 30 and 
60 minutes after restarting of CPB (group I: 3.35 _ 
0.73 and 5.00 -+ 1.57 mm Hg/ml per 100 gm per 
minute; group II: 1.30 __ 0.33 and 1.03 + 0.17 mm 
Hg/ml per 100 gm per minute; group III: 1.24 _ 0.41 
and 0.98 _+ 0.24 mm Hg/ml per 100 gm per minute). 
Cerebral metabolism. Oxygen and glucose ex- 
traction levels are shown in Fig. 4, A and B. The 
oxygen extraction level was reduced by cooling, but 
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it rose to a higher level as a result of significant 
desaturation of returned blood even in deep hypo- 
thermia during RCP. The oxygen extraction level 
showed a rapid decrease after CPB was restarted 
and gradually increased uring rewarming. The glu- 
cose extraction level was also observed to increase 
during RCP. Both CMRO2 and CMRGlu were 
reduced by cooling and remained at low levels 
during RCP. Although there were no significant 
differences among the three groups during the ex- 
perimental protocol, CMRO2 and CMRGIu were 
not elevated by rewarming during CPB in group I 
(Fig. 4, C and D). CBF/CMRO 2 and CBF/CMRGlu 
were elevated uring cooling and early rewarming 
states. However, these values were markedly re- 
duced during RCP even in deep hypothermia (Fig. 
4, E and F). 
Intracranial pressure. Intracranial pressure did 
not increase by the end of RCP. After CPB was 
restarted, intracranial pressure did not increase in 
dogs that received mannitol (group II) or antivaso- 
spastic substance (group III), whereas in untreated 
dogs (group I), it showed significant increases 30 
and 60 minutes after CPB was restarted (group I: 
22.7 + 2.8 and 20.6 + 5.1 mm Hg; group II: 6.3 _+ 
1.8 and 5.3 _+ 1.3 mm Hg; group III: 4.2 _+ 1.7 and 
7.7 _+ 2.8 mm Hg) (Fig. 5). 
Water content of the brain tissue. Water content 
of the brain tissue in dogs that received mannitol 
(group II: 74.71% -+ 0.76%) or antivasospastic 
substance (group III: 74.14% _+ 0.48%) was signifi- 
cantly lower than that in untreated ogs (group I: 
77.54% _+ 0.29%) (Fig. 6). 
Discussion 
RCP via the superior vena cava is a new technique 
of brain protection during aortic arch operation and 
is widely used today. 6-m RCP is a simple method 
that does not need special equipment, cannulation, 
or clamping of the arch vessels. RCP can flush out 
air and atheromatous debris in the cerebral vessels 
and maintain the desired cerebral temperature by 
cooling of the perfused blood. 7' 9 Furthermore, it
may reduce ischemic damage to the brain by pro- 
viding oxygen, glucose, 11 and cerebral protective 
agents as a form of pharmacologic intervention. 
However, it is not clear whether this method pro: 
vides adequate cerebral oxygenation or how long it 
can be done safely. ~1 In this study, we report results 
from our measurements of CBF, CVR, parameters 
of cerebral metabolism, intracranial pressure, and 
water content of the brain tissue. Moreover, we 
assessed the effects of pharmacologic ntervention 
for cerebral protection during and after RCP. In this 
experiment, an RCP period of 120 minutes was 
selected to simulate most aortic arch operations, 
and blood was perfused via the bilateral internal 
maxillary veins to avoid venous valves that would 
interfere with retrograde perfusion. 11 
Values for CBF, CMRO2, and CMRGlu were 
markedly reduced by hypothermic CPB as was ex- 
pected. 14"17 We found that half of the CBF was 
provided during RCP compared with that during; 
CPB with hypothermia. This result was in accord[ 
with that of Usui and associates. 11 Values for 
CMRO 2 and CMRGlu showed no remarkable', 
changes during 120 minutes of RCP. However, it is 
thought that cerebral metabolism during RCP is 
insufficient to prevent cerebral injury. During RCP, 
returned blood sampled from the carotid artery 
revealed marked desaturation, which reflected an 
elevation of oxygen extraction. Increased oxygen 
extraction would be the compensatory response 
when oxygen demand is much higher than the 
oxygen supply. 16 The relationship between the, 
changes in CBF and cerebral metabolism can be 
summarized by the CBF/CMRO2 ratio. 16' 17 The 
CBF/CMRO2 ratio increased during hypothermic 
CPB, showing so-called "luxury perfusion." On the 
other hand, it showed a significant decrease during 
RCP even with deep hypothermia. The discordance 
between CBF and cerebral metabolism suggests that 
a disturbance in cerebral autoregulation ccurs dur- 
ing RCP. 
In the untreated group (group I), CBF gradually 
decreased and CVR significantly increased after 
CPB was restarted. Mezrow and associates 17and 
Anstadt and associates is have both demonstrated a 
similar phenomenon after deep hypothermic circu- 
latory arrest. Mezrow and associates 17 suggested 
that the late reperfusion period after hypothermic 
circulatory arrest is the time when the brain is 
particularly vulnerable to injury. In our study, intra- 
cranial pressure showed a significant increase simul- 
taneous with the elevation of CVR in untreated 
dogs. Moreover, water content of the brain tissue in 
untreated ogs (group I) was significantly higher 
than that in dogs that received mannitol (group II) 
or antivasospastic substance (group III). These re- 
sults suggest that brain edema might develop during 
the reperfusion period after RCP. 
Recently, three mechanisms of ischemic brain 
damage have been the focus of interest. These are 
elevation of intracellular Ca 2+, excessive acidosis, 
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Fig. 4. Changes of cerebral metabolism during experimental protocol. A, O 2 extraction. B, Glucose 
extraction. C, CMRO2. D, CMRGlu. E, CBF/CMRO 2 ratio. F, CBF/CMRGlu ratio, reCPB, Restarting of 
CPB. 
and enhanced production of free radicals. 19 Abnor- 
mal influx of Ca a+ occurs via activation of receptors 
by glutamate and associated excitatory amino ac- 
ids.19, 20 An excessive Ca 2+ level causes overactiva- 
tion of phospholipases and proteases, which results 
in cell injury. 21 Excessive acidosis enhances devel- 
opment of edema by inducing Na + and CI-  accu- 
mulation via coupled Na+/H + and C1 /HCO 3 ex- 
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change, a9 Although free radicals have been widely 
recognized as factors responsible for tissue injury 
after reperfusion, their role in the pathogenesis of
brain damage after sustained ischemia nd reperfu- 
sion has not been clearly understood. Recent studies 
revealed that free radicals primarily affect microves- 
sels and increase microvascular permeability, which 
causes ischemic brain edema) 9'22, 23 On the basis of 
these findings, numerous trials of pharmacologic 
intervention, including use of calcium antagonists, 21 
glutamate r ceptor blockers, 2°' 24, 25 and free radical 
scavengers,a3, 2 , 26 have been made to ameliorate 
ischemic brain damage. 
In this study, we selected mannitol and antivaso- 
spastic substance 13 as cerebral protective agents. It 
is well accepted that water supply and brain cell 
damage are prerequisites for the development of
brain edema and that the blockade of such water 
supply or inhibition of brain cell damage may pre- 
vent its occurrence. Mannitol, a hyperosmotic agent 
that can preserve water in the vascular lumen, may 
prevent the development of ischemic brain edema. 77 
In addition, it is known that mannitol shows the 
effect of a free radical scavenger, which may en- 
hance the protective ffect for brain tissue. 28 Anti- 
vasospastic substance is a free-radical scavenger that 
1 1 8 0 Yoshimura et aL 
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is currently being subjected to clinical trials as a 
cerebral protective agent hat may inhibit the devel- 
opment of ischemic brain edema. Koide and associ- 
ates 22 demonstrated that the eicosanoids, which are 
the products derived from the arachidonate cascade, 
synthetic apacity in the cerebral microvessels are 
enhanced after ischemia probably because of gener- 
ation of free radicals, as well as the increased 
availability of free arachidonate, and that this pro- 
cess is related to the increase in the permeability of 
the blood-brain barrier to sodium. It is thought hat 
antivasospastic substance suppresses the increased 
influx of water and sodium across the blood-brain 
barrier by the inhibition of increased production of 
eicosanoids in the cerebral microvessels. 13 Our ex- 
perimental study suggests that mannitol and antiva- 
sospastic substance may be useful pharmacologic 
agents even during deep hypothermic RCP; how- 
ever, their therapeutic value needs to be further 
examined especially in deep hypothermia. 
In summary, RCP is a useful technique for cere- 
bral protection during aortic arch operation. How- 
ever, the supply of oxygen or glucose by RCP is not 
enough to maintain sufficient cerebral metabolism, 
which may cause brain edema after antegrade cere- 
bral blood perfusion is restarted. Therefore cerebral 
protection via pharmacologic agents (such as man- 
nitol or antivasospastic substance) is recommended 
to prevent neurologic omplications during aortic 
arch operation with the use of RCP. 
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